FT Options LLC historic quarter change: USA Options, Added
In put and call options, at their filed underlying value (listed in the US), over 3 quarters from 2015-12-31 to 2016-09-30, FT Options LLC opened 380 positions, added to 184, reduced 130 and sold out of 230.
- Q3 2016: Stock GW PHARMACEUTICALS PLC; Country of operation —; Class ADS · Call; Shares before 129,800.
- Q3 2016: Stock INTERCEPT PHARMACEUTICALS IN; Country of operation United States; Class COM · Call; Shares before 20,200.
- Q3 2016: Stock REGN; Country of operation United States; Class COM · Put; Shares before 47,000.
- Q3 2016: Stock BMY; Country of operation United States; Class COM · Put; Shares before 50,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1594954), 3 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2015-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2016 | GW PHARMACEUTICALS PLC CUSIP 36197T103 | ADS · Call | 129,800 | 131,100 | +1,300 | $1,535,000 | $5,155,000 | +$3,620,000 | 2016-11-10 | |
| Q3 2016 | INTERCEPT PHARMACEUTICALS IN CUSIP 45845P108 | United States | COM · Call | 20,200 | 78,500 | +58,300 | $25,000 | $2,013,000 | +$1,988,000 | 2016-11-10 |
| Q3 2016 | REGN REGENERON PHARMACEUTICALS | United States | COM · Put | 47,000 | 74,300 | +27,300 | $7,582,000 | $5,689,000 | -$1,893,000 | 2016-11-10 |
| Q3 2016 | BMY BRISTOL MYERS SQUIBB CO | United States | COM · Put | 50,000 | 97,200 | +47,200 | $123,000 | $1,309,000 | +$1,186,000 | 2016-11-10 |
| Q3 2016 | PG PROCTER AND GAMBLE CO | United States | COM · Put | 15,000 | 61,500 | +46,500 | $45,000 | $1,230,000 | +$1,185,000 | 2016-11-10 |
| Q3 2016 | EXEL EXELIXIS INC | United States | COM · Call | 190,700 | 236,300 | +45,600 | $310,000 | $1,349,000 | +$1,039,000 | 2016-11-10 |
| Q3 2016 | SRPT SAREPTA THERAPEUTICS INC | United States | COM · Put | 95,000 | 105,500 | +10,500 | $985,000 | $20,000 | -$965,000 | 2016-11-10 |
| Q3 2016 | SRPT SAREPTA THERAPEUTICS INC | United States | COM · Call | 43,500 | 173,300 | +129,800 | $203,000 | $1,098,000 | +$895,000 | 2016-11-10 |
| Q3 2016 | GIS GENERAL MLS INC | United States | COM · Call | 170,900 | 339,500 | +168,600 | $839,000 | $47,000 | -$792,000 | 2016-11-10 |
| Q3 2016 | ISRG INTUITIVE SURGICAL INC | United States | COM NEW · Call | 10,500 | 26,900 | +16,400 | $360,000 | $1,030,000 | +$670,000 | 2016-11-10 |
| Q3 2016 | AAPL APPLE INC | United States | COM · Call | 42,300 | 48,600 | +6,300 | $225,000 | $691,000 | +$466,000 | 2016-11-10 |
| Q3 2016 | ULTA ULTA SALON COSMETCS & FRAG I | United States | COM · Call | 18,000 | 23,800 | +5,800 | $504,000 | $76,000 | -$428,000 | 2016-11-10 |
| Q3 2016 | GIS GENERAL MLS INC | United States | COM · Put | 20,000 | 68,600 | +48,600 | $2,000 | $393,000 | +$391,000 | 2016-11-10 |
| Q3 2016 | KMB KIMBERLY CLARK CORP | United States | COM · Call | 134,500 | 155,900 | +21,400 | $452,000 | $69,000 | -$383,000 | 2016-11-10 |
| Q3 2016 | REGN REGENERON PHARMACEUTICALS | United States | COM · Call | 25,500 | 47,000 | +21,500 | $418,000 | $777,000 | +$359,000 | 2016-11-10 |
| Q3 2016 | PTCT PTC THERAPEUTICS INC | United States | COM · Call | 90,400 | 100,400 | +10,000 | $116,000 | $451,000 | +$335,000 | 2016-11-10 |
| Q3 2016 | CONCORDIA INTL CORP CUSIP 20653P102 | COM · Put | 17,500 | 21,000 | +3,500 | $348,000 | $17,000 | -$331,000 | 2016-11-10 | |
| Q3 2016 | OPHTHOTECH CORP CUSIP 683745103 | COM · Call | 11,300 | 55,100 | +43,800 | $170,000 | $417,000 | +$247,000 | 2016-11-10 | |
| Q3 2016 | YUM YUM BRANDS INC | United States | COM · Call | 27,500 | 47,500 | +20,000 | $122,000 | $352,000 | +$230,000 | 2016-11-10 |
| Q3 2016 | ESPR ESPERION THERAPEUTICS INC NE | United States | COM · Call | 85,500 | 110,600 | +25,100 | $195,000 | $421,000 | +$226,000 | 2016-11-10 |
| Q3 2016 | HUM HUMANA INC | United States | COM · Call | 29,000 | 34,600 | +5,600 | $399,000 | $174,000 | -$225,000 | 2016-11-10 |
| Q3 2016 | CLOVIS ONCOLOGY INC CUSIP 189464100 | COM · Call | 24,400 | 54,400 | +30,000 | $7,000 | $212,000 | +$205,000 | 2016-11-10 | |
| Q3 2016 | CELGENE CORP CUSIP 151020104 | COM · Call | 25,000 | 186,300 | +161,300 | $10,000 | $201,000 | +$191,000 | 2016-11-10 | |
| Q3 2016 | ULTA ULTA SALON COSMETCS & FRAG I | United States | COM · Put | 9,500 | 18,800 | +9,300 | $83,000 | $264,000 | +$181,000 | 2016-11-10 |
| Q3 2016 | ACN ACCENTURE PLC IRELAND | SHS CLASS A · Put | 39,900 | 53,600 | +13,700 | $236,000 | $56,000 | -$180,000 | 2016-11-10 | |
| Q3 2016 | YUM YUM BRANDS INC | United States | COM · Put | 27,500 | 78,500 | +51,000 | $105,000 | $283,000 | +$178,000 | 2016-11-10 |
| Q3 2016 | BMRN BIOMARIN PHARMACEUTICAL INC | United States | COM · Call | 5,000 | 48,600 | +43,600 | $15,000 | $175,000 | +$160,000 | 2016-11-10 |
| Q3 2016 | TIME WARNER INC CUSIP 887317303 | COM NEW · Call | 40,500 | 96,800 | +56,300 | $17,000 | $154,000 | +$137,000 | 2016-11-10 | |
| Q3 2016 | ABT ABBOTT LABS | United States | COM · Call | 11,500 | 22,500 | +11,000 | $89,000 | $224,000 | +$135,000 | 2016-11-10 |
| Q3 2016 | XILINX INC CUSIP 983919101 | COM · Call | 56,400 | 95,100 | +38,700 | $9,000 | $137,000 | +$128,000 | 2016-11-10 | |
| Q3 2016 | BMY BRISTOL MYERS SQUIBB CO | United States | COM · Call | 50,000 | 232,500 | +182,500 | $173,000 | $49,000 | -$124,000 | 2016-11-10 |
| Q3 2016 | SPY SPDR S&P 500 ETF TR | TR UNIT · Put | 7,000 | 52,500 | +45,500 | $11,000 | $132,000 | +$121,000 | 2016-11-10 | |
| Q3 2016 | ARWR ARROWHEAD PHARMACEUTICALS IN | United States | COM · Call | 85,800 | 88,800 | +3,000 | $114,000 | $233,000 | +$119,000 | 2016-11-10 |
| Q3 2016 | CABELAS INC CUSIP 126804301 | COM · Call | 16,100 | 27,200 | +11,100 | $26,000 | $144,000 | +$118,000 | 2016-11-10 | |
| Q3 2016 | GILD GILEAD SCIENCES INC | United States | COM · Put | 154,200 | 164,000 | +9,800 | $387,000 | $270,000 | -$117,000 | 2016-11-10 |
| Q3 2016 | FIVE FIVE BELOW INC | United States | COM · Put | 52,800 | 57,800 | +5,000 | $105,000 | $218,000 | +$113,000 | 2016-11-10 |
| Q3 2016 | OPHTHOTECH CORP CUSIP 683745103 | COM · Put | 12,000 | 17,000 | +5,000 | $250,000 | $355,000 | +$105,000 | 2016-11-10 | |
| Q3 2016 | TGT TARGET CORP | United States | COM · Call | 70,000 | 85,000 | +15,000 | $165,000 | $61,000 | -$104,000 | 2016-11-10 |
| Q3 2016 | LULU LULULEMON ATHLETICA INC | COM · Call | 24,000 | 30,500 | +6,500 | $104,000 | $1,000 | -$103,000 | 2016-11-10 | |
| Q3 2016 | ORCL ORACLE CORP | United States | COM · Put | 30,000 | 42,800 | +12,800 | $10,000 | $113,000 | +$103,000 | 2016-11-10 |
| Q3 2016 | CHD CHURCH & DWIGHT INC | United States | COM · Call | 17,800 | 37,200 | +19,400 | $106,000 | $9,000 | -$97,000 | 2016-11-10 |
| Q3 2016 | CCEP COCA COLA EUROPEAN PARTNERS | SHS · Call | 19,400 | 64,200 | +44,800 | $25,000 | $117,000 | +$92,000 | 2016-11-10 | |
| Q3 2016 | ADBE ADOBE SYS INC | United States | COM · Put | 30,000 | 34,900 | +4,900 | $45,000 | $133,000 | +$88,000 | 2016-11-10 |
| Q3 2016 | KO COCA COLA CO | United States | COM · Call | 180,900 | 251,200 | +70,300 | $97,000 | $15,000 | -$82,000 | 2016-11-10 |
| Q3 2016 | MDLZ MONDELEZ INTL INC | United States | CL A · Put | 5,000 | 52,500 | +47,500 | $16,000 | $98,000 | +$82,000 | 2016-11-10 |
| Q3 2016 | ALLERGAN PLC CUSIP G0177J108 | SHS · Call | 10,300 | 10,800 | +500 | $102,000 | $21,000 | -$81,000 | 2016-11-10 | |
| Q3 2016 | PAIN THERAPEUTICS INC CUSIP 69562K100 | COM · Put | 75,000 | 87,000 | +12,000 | $56,000 | $128,000 | +$72,000 | 2016-11-10 | |
| Q3 2016 | DU PONT E I DE NEMOURS & CO CUSIP 263534109 | COM · Call | 27,100 | 71,000 | +43,900 | $35,000 | $99,000 | +$64,000 | 2016-11-10 | |
| Q3 2016 | MDLZ MONDELEZ INTL INC | United States | CL A · Call | 76,000 | 191,600 | +115,600 | $112,000 | $176,000 | +$64,000 | 2016-11-10 |
| Q3 2016 | BLUEBIRD BIO INC CUSIP 09609G100 | United States | COM · Call | 25,800 | 38,300 | +12,500 | $5,000 | $68,000 | +$63,000 | 2016-11-10 |
| Q3 2016 | MSFT MICROSOFT CORP | United States | COM · Put | 36,400 | 71,200 | +34,800 | $62,000 | $125,000 | +$63,000 | 2016-11-10 |
| Q3 2016 | A AGILENT TECHNOLOGIES INC | United States | COM · Call | 82,500 | 142,000 | +59,500 | $29,000 | $91,000 | +$62,000 | 2016-11-10 |
| Q3 2016 | JAZZ JAZZ PHARMACEUTICALS PLC | SHS USD · Call | 24,100 | 25,100 | +1,000 | $64,000 | $3,000 | -$61,000 | 2016-11-10 | |
| Q3 2016 | ABBV ABBVIE INC | United States | COM · Put | 16,600 | 36,600 | +20,000 | $1,000 | $60,000 | +$59,000 | 2016-11-10 |
| Q3 2016 | KMB KIMBERLY CLARK CORP | United States | COM · Put | 2,500 | 30,000 | +27,500 | $2,000 | $60,000 | +$58,000 | 2016-11-10 |
| Q3 2016 | BANK OF THE OZARKS INC CUSIP 063904106 | COM · Put | 20,000 | 57,000 | +37,000 | $104,000 | $160,000 | +$56,000 | 2016-11-10 | |
| Q3 2016 | ASML ASML HOLDING N V | N Y REGISTRY SHS · Put | 9,700 | 14,200 | +4,500 | $59,000 | $13,000 | -$46,000 | 2016-11-10 | |
| Q3 2016 | CYBR CYBERARK SOFTWARE LTD | SHS · Call | 24,900 | 28,200 | +3,300 | $57,000 | $12,000 | -$45,000 | 2016-11-10 | |
| Q3 2016 | TIME WARNER INC CUSIP 887317303 | COM NEW · Put | 5,000 | 32,500 | +27,500 | $52,000 | $94,000 | +$42,000 | 2016-11-10 | |
| Q3 2016 | FIVE FIVE BELOW INC | United States | COM · Call | 9,600 | 19,600 | +10,000 | $64,000 | $28,000 | -$36,000 | 2016-11-10 |
| Q3 2016 | BLUEBIRD BIO INC CUSIP 09609G100 | United States | COM · Put | 10,700 | 20,700 | +10,000 | $79,000 | $44,000 | -$35,000 | 2016-11-10 |
| Q3 2016 | M MACYS INC | United States | COM · Call | 40,400 | 60,400 | +20,000 | $46,000 | $81,000 | +$35,000 | 2016-11-10 |
| Q3 2016 | INSM INSMED INC | United States | COM PAR $.01 · Call | 16,600 | 31,600 | +15,000 | $2,000 | $36,000 | +$34,000 | 2016-11-10 |
| Q3 2016 | MONSANTO CO NEW CUSIP 61166W101 | COM · Call | 31,100 | 46,200 | +15,100 | $98,000 | $67,000 | -$31,000 | 2016-11-10 | |
| Q3 2016 | TJX TJX COS INC NEW | United States | COM · Call | 40,000 | 70,000 | +30,000 | $52,000 | $23,000 | -$29,000 | 2016-11-10 |
| Q3 2016 | RITE AID CORP CUSIP 767754104 | COM · Call | 30,000 | 80,000 | +50,000 | $41,000 | $68,000 | +$27,000 | 2016-11-10 | |
| Q3 2016 | VEEV VEEVA SYS INC | United States | CL A COM · Call | 20,000 | 39,900 | +19,900 | $22,000 | $49,000 | +$27,000 | 2016-11-10 |
| Q3 2016 | GW PHARMACEUTICALS PLC CUSIP 36197T103 | ADS · Put | 45,500 | 78,900 | +33,400 | $338,000 | $362,000 | +$24,000 | 2016-11-10 | |
| Q3 2016 | TGT TARGET CORP | United States | COM · Put | 5,000 | 40,000 | +35,000 | $6,000 | $29,000 | +$23,000 | 2016-11-10 |
| Q3 2016 | IBM INTERNATIONAL BUSINESS MACHS | United States | COM · Call | 12,500 | 14,400 | +1,900 | $91,000 | $113,000 | +$22,000 | 2016-11-10 |
| Q3 2016 | QCOM QUALCOMM INC | United States | COM · Put | 16,400 | 31,400 | +15,000 | $42,000 | $21,000 | -$21,000 | 2016-11-10 |
| Q3 2016 | CLOVIS ONCOLOGY INC CUSIP 189464100 | COM · Put | 10,000 | 72,800 | +62,800 | $21,000 | $42,000 | +$21,000 | 2016-11-10 | |
| Q3 2016 | TAP MOLSON COORS BREWING CO | CL B · Call | 5,600 | 8,400 | +2,800 | $29,000 | $50,000 | +$21,000 | 2016-11-10 | |
| Q3 2016 | GILD GILEAD SCIENCES INC | United States | COM · Call | 47,300 | 137,700 | +90,400 | $77,000 | $57,000 | -$20,000 | 2016-11-10 |
| Q3 2016 | CELLDEX THERAPEUTICS INC NEW CUSIP 15117B103 | COM · Call | 7,200 | 25,000 | +17,800 | $1,000 | $20,000 | +$19,000 | 2016-11-10 | |
| Q3 2016 | HRTX HERON THERAPEUTICS INC | United States | COM · Call | 20,200 | 32,200 | +12,000 | $30,000 | $11,000 | -$19,000 | 2016-11-10 |
| Q3 2016 | NETSUITE INC CUSIP 64118Q107 | COM · Call | 10,000 | 12,000 | +2,000 | $6,000 | $24,000 | +$18,000 | 2016-11-10 | |
| Q3 2016 | POST POST HLDGS INC | United States | COM · Call | 11,000 | 24,100 | +13,100 | $72,000 | $56,000 | -$16,000 | 2016-11-10 |
| Q3 2016 | MAT MATTEL INC | United States | COM · Put | 4,000 | 23,500 | +19,500 | $10,000 | $25,000 | +$15,000 | 2016-11-10 |
| Q3 2016 | CL COLGATE PALMOLIVE CO | United States | COM · Put | 2,000 | 2,500 | +500 | $2,000 | $16,000 | +$14,000 | 2016-11-10 |
| Q3 2016 | DSW INC CUSIP 23334L102 | CL A · Call | 15,000 | 25,000 | +10,000 | $15,000 | $2,000 | -$13,000 | 2016-11-10 | |
| Q3 2016 | PEP PEPSICO INC | United States | COM · Call | 165,000 | 208,000 | +43,000 | $129,000 | $141,000 | +$12,000 | 2016-11-10 |
| Q3 2016 | AETNA INC NEW CUSIP 00817Y108 | COM · Call | 12,500 | 14,600 | +2,100 | $12,000 | $2,000 | -$10,000 | 2016-11-10 | |
| Q3 2016 | HSY HERSHEY CO | United States | COM · Put | 4,200 | 4,800 | +600 | $2,000 | $11,000 | +$9,000 | 2016-11-10 |
| Q3 2016 | CRM SALESFORCE COM INC | United States | COM · Put | 12,500 | 16,200 | +3,700 | $120,000 | $112,000 | -$8,000 | 2016-11-10 |
| Q3 2016 | TAP MOLSON COORS BREWING CO | CL B · Put | 6,600 | 20,900 | +14,300 | $14,000 | $21,000 | +$7,000 | 2016-11-10 | |
| Q3 2016 | ORCL ORACLE CORP | United States | COM · Call | 20,000 | 20,200 | +200 | $13,000 | $8,000 | -$5,000 | 2016-11-10 |
| Q3 2016 | RAPTOR PHARMACEUTICAL CORP CUSIP 75382F106 | COM · Put | 8,400 | 87,700 | +79,300 | $6,000 | $8,000 | +$2,000 | 2016-11-10 | |
| Q3 2016 | ZIOPHARM ONCOLOGY INC CUSIP 98973P101 | COM · Put | 100,000 | 138,500 | +38,500 | $88,000 | $86,000 | -$2,000 | 2016-11-10 | |
| Q3 2016 | BBY BEST BUY INC | United States | COM · Put | 15,000 | 21,700 | +6,700 | $32,000 | $32,000 | $0 | 2016-11-10 |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||